SM
KYNB

Sabby Management’s Kyntra Bio KYNB Stock Holding History

Sabby Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-57
Closed -$5.83M – 128
2020
Q3 		$5.83M Buy
57
+1
+2% +$1.08K 0.87% 25
2020
Q2 		$5.7M Buy
56
+42
+300% +$39K 1.14% 18
2020
Q1 		$1.25M Buy
+14
New +$13.9K 0.52% 21
2019
Q2 		– Sell
-44
Closed -$5.95M – 97
2019
Q1 		$5.95M Buy
44
+7
+19% +$9.49K 2.86% 5
2018
Q4 		$4.24M Sell
37
-21
-36% -$23.6K 0.93% 16
2018
Q3 		$8.77M Buy
58
+43
+287% +$66.2K 1.12% 20
2018
Q2 		$2.29M Buy
+15
New +$19.6K 0.35% 41

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Sabby Management's KYNB Position: Q4 2020 in Review

Sabby Management sold out of Kyntra Bio (KYNB) in Q4 2020, closing a stake of 1,186 shares — an estimated $1.22M sold.

Sabby Management first reported a position in KYNB in Q1 2015 and held it in 12 quarters. The position peaked at $2.32M in Q1 2016. 207 funds tracked by Wall St. Rank hold KYNB as of Q4 2020.

  • Sabby Management reported no remaining Kyntra Bio position as of Q4 2020 after selling out during the quarter.
  • Sabby Management sold 1,186 Kyntra Bio shares in Q4 2020, an estimated $1.22M.
  • Sabby Management first reported a position in Kyntra Bio in Q1 2015 and held it in 12 quarters.
  • Sabby Management's Kyntra Bio position peaked at $2.32M in Q1 2016.
  • 207 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.